POLL: Which Most Recent FDA Approval Are You Excited About?

Click here to answer this week's poll.

Which Most Recent FDA Approval Are You Excited About?

Sirolimus topical gel 0.2% for facial angiofibromas with tuberous sclerosis complex
Ruxolitinib cream 1.5% for nonsegmental vitiligo
Baricitinib for alopecia areata
Roflumilast cream 0.3% for plaque psoriasis
Ustekinumab for pediatric psoriatic arthritis
Hyaluronic acid filler for loss of jawline definition
Related Content

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023

POLL: What Skin Condition is Caused by Poxvirus?

February 23rd 2023

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023

POLL: What Skin Condition is Caused by Poxvirus?

February 23rd 2023

POLL: What Will Catch Your Eye In The AAD Exhibit Hall?

March 15th 2023

POLL: What Are You Most Looking Forward to at AAD 2023?

March 14th 2023

POLL: Are You Attending AAD 2023?

March 13th 2023

POLL: What is a Precursor to Squamous Cell Carcinoma?

March 6th 2023

POLL: What is the Most Common Type of Mole Found on Adults?

February 27th 2023

POLL: What Skin Condition is Caused by Poxvirus?

February 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.